Search

Your search keyword '"Chau, Kevin"' showing total 411 results

Search Constraints

Start Over You searched for: Author "Chau, Kevin" Remove constraint Author: "Chau, Kevin"
411 results on '"Chau, Kevin"'

Search Results

2. Author Correction: The plasmidome associated with Gram-negative bloodstream infections: a large-scale observational study using complete plasmid assemblies

3. The plasmidome associated with Gram-negative bloodstream infections: A large-scale observational study using complete plasmid assemblies

5. MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

6. Reorganization in the macaque interoceptive-allostatic network following anterior cingulate cortex damage

7. Reclassification of the Etiology of Infant Mortality With Whole-Genome Sequencing

8. Scalable, high quality, whole genome sequencing from archived, newborn, dried blood spots

9. Optimization of a Real-Time Wavelet-Based Algorithm for Improving Speech Intelligibility

11. Contact map dependence of a T cell receptor binding repertoire

12. Wastewater influent and population-level surveillance of antimicrobial resistance in Oxfordshire using metagenomic sequencing

13. An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases

14. Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism

15. Autism-linked Cullin3 germline haploinsufficiency impacts cytoskeletal dynamics and cortical neurogenesis through RhoA signaling

16. Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer

17. Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer.

18. Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

20. Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals

21. Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria

23. COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

24. Population-level faecal metagenomic profiling as a tool to predict antimicrobial resistance in Enterobacterales isolates causing invasive infections: An exploratory study across Cambodia, Kenya, and the UK

25. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

26. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

29. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia

30. Does environmental exposure to pharmaceutical and personal care product residues result in the selection of antimicrobial-resistant microorganisms, and is this important in terms of human health outcomes?

34. Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody–Drug Conjugate for Treatment of CLDN18.2-Positive Cancers

35. Data from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

36. Supplementary Fig. 2 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

37. Supplementary Fig. 5 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

38. Supplementary Fig. 1 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

39. Supplementary Fig. 4 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

40. Supplementary Fig. 3 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

41. Supplementary Data 1 from MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling

43. Reclassification of the Etiology of Infant Mortality With Whole-Genome Sequencing

46. Reorganization in the macaque interoceptive-allostatic network following anterior cingulate cortex damage.

47. High-resolution characterization of short-term temporal variability in the taxonomic and resistome composition of wastewater influent

48. Enterobacterales plasmid sharing amongst human bloodstream infections, livestock, wastewater, and waterway niches in Oxfordshire, UK

49. A longitudinal study reveals persistence of antimicrobial resistance on livestock farms is not due to antimicrobial usage alone

50. Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors

Catalog

Books, media, physical & digital resources